|
|
|
Volumn , Issue 101, 2007, Pages 1-4
|
|
Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
TISSUE EXTRACT;
ARTICLE;
CANADA;
CLINICAL TRIAL;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MALE;
METHODOLOGY;
PROSTATE TUMOR;
TREATMENT OUTCOME;
CANADA;
CANCER VACCINES;
CLINICAL TRIALS;
HUMANS;
IMMUNOTHERAPY;
MALE;
PROSTATIC NEOPLASMS;
TISSUE EXTRACTS;
TREATMENT OUTCOME;
|
|
EID: 34548653937
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
